Johnson & Johnson on Monday announced that Mark McClellan, senior fellow in economic studies and director of the Initiative on Value and Innovation in Health Care at the Brookings Institution, will join the company's board of directors on Oct. 15. McClellan will serve on the regulatory, compliance and government affairs committee, as well as the science, technology and sustainability committee.
Canadian pharmacy chain The Jean Coutu Group, which operates a network of 407 franchised stores in Quebec, New Brunswick and Ontario, reported a drop in net income in its first quarter, largely due to much smaller gains from the sale of Rite Aid shares versus the year-earlier period, the company stated.
When does the double-edged sword of generic drug price reductions begin to cut the government agency or health system holding the sword?
That's the question many pharmacy leaders in Canada have for the provincial health system policy-makers who have embarked on a crusade to whack pharmacy reimbursement levels for many lower-cost generic medicines sold under the nation's publicly funded health system.
Johnson & Johnson chairman and CEO Alex Gorsky last week told shareholders that its consumer healthcare business would reclaim its prominence in the U.S. marketplace at the company's annual shareholder meeting. But OTC growth will be greatest outside of the United States.
Johnson & Johnson Consumer earlier this summer put the freeze on pain with the launch of its Bengay Zero Degrees line extension, an external analgesic rub that makes its home alongside the frozen peas in the freezer.
Johnson & Johnson Consumer Cos. last week voluntarily recalled from retailers one lot of Aveeno Baby Calming Comfort lotion that was distributed in Alabama, Arkansas, Florida, Georgia, Kansas, Louisiana, Mississippi, Tennessee and Texas.
Johnson & Johnson is preparing to turn the corner with its McNeil Consumer Healthcare business, J&J chairman and CEO William Weldon told analysts during the company's fourth-quarter earnings call Tuesday.
Johnson & Johnson Tuesday morning pledged significant support behind the relaunch of several McNeil Consumer products into the marketplace in 2012, and feels confident impacted brands — Tylenol and Motrin, among others — will be able to recapture market share, despite significant private-label erosion.
Johnson & Johnson chairman and CEO Bill Weldon on Wednesday morning rang the NYSE opening bell remotely from Johnson & Johnson world headquarters here as part of the company's employee celebration of its 125th anniversary.
Johnson & Johnson on Thursday announced that the company has entered into an agreement to become a global sponsor of the 2014 FIFA World Cup Brazil, becoming the eighth and final FIFA World Cup Sponsor.
Drug maker Johnson & Johnson plans to file for regulatory approval for 11 new drugs between 2011 and 2015, the company said Thursday in relation to a meeting between J&J’s executive committee and investors.
Johnson & Johnson on Tuesday announced that distribution of McNeil Consumer Healthcare consumer products will slow in the coming months as the company shifts production of its over-the-counter medicines to other manufacturing plants and implements additional third-party quality controls within those plants.